CompletedEarly Phase 1

Crestal Bone Loss in Mandibular Telescopic Overdentures. Overdenture with Milled Titanium, Milled Poly-ether Ketone Ketones and 3D Printed Chrome Cobalt Secondary Copings.

Egypt30 participantsStarted 2023-08-01

Plain-language summary

The objective of this clinical trial is to evaluate crestal bone loss every three months at time of overdenture insertion, 3, 6, 9, 12 months from overdenture use. Also, to evaluate prosthesis satisfaction. All participants will receive conventional complete dentures, followed by two intraforaminal implants. After healing time, fabrication of secondary copings in all cases according to randomized groups for final overdenture insertion.

Who can participate

Age range55 Years – 75 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. Sufficient remaining bone in height, width and thickness in the interforaminal area to allow installation of at least 3.3 mm diameter and 8 mm length implants.
✓. Adequate amount of interarch space of at least 12mm.
✓. Age range from 55 to 75 years old age.

Exclusion criteria

✕. Systemic and metabolic diseases that may affect osseointegration.
✕. Patients receiving bisphosphonates therapy.
✕. Patients under radiotherapy or chemotherapy.

What they're measuring

Crestal bone loss.

Timeframe: one year

Trial details

NCT IDNCT06639893

SponsorCairo University

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2024-08-01

View on ClinicalTrials.gov More Telescopic Overdentures trials